These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11275700)

  • 1. Antiproliferative effect of somatostatin and analogs.
    Bousquet C; Puente E; Buscail L; Vaysse N; Susini C
    Chemotherapy; 2001; 47 Suppl 2():30-9. PubMed ID: 11275700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of somatostatin.
    Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
    Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
    Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogs and radiopeptides in cancer therapy.
    Froidevaux S; Eberle AN
    Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of antineoplastic action of somatostatin analogs.
    Pollak MN; Schally AV
    Proc Soc Exp Biol Med; 1998 Feb; 217(2):143-52. PubMed ID: 9452137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of somatostatin analogs in the management of prostate cancer.
    Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
    J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regulation of cell proliferation by somatostatin].
    Buscail L; Vernejoul F; Faure P; Torrisani J; Susini C
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S13-8. PubMed ID: 12037498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its anti-proliferative activity on human oral carcinoma cells in vitro.
    Dasgupta P; Singh AT; Mukherjee R
    Life Sci; 2000 Mar; 66(17):1557-70. PubMed ID: 11261586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for treating cancer with somatostatin analogs.
    Minuto F; Ferone D; Arvigo M; Barreca A
    J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple actions of somatostatin in neoplastic disease.
    Reubi JC; Laissue JA
    Trends Pharmacol Sci; 1995 Mar; 16(3):110-5. PubMed ID: 7792931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
    Hasskarl J; Kaufmann M; Schmid HA
    Future Oncol; 2011 Jul; 7(7):895-913. PubMed ID: 21732759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analog SMS 201995 inhibits proliferation in human leukemia T-cell line: relevance of the adenylyl cyclase stimulation.
    Giannetti N; Enjalbert A; Krantic S
    J Cell Biochem; 2000 Jun; 78(4):666-73. PubMed ID: 10861863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells.
    Florio T; Rim C; Hershberger RE; Loda M; Stork PJ
    Mol Endocrinol; 1994 Oct; 8(10):1289-97. PubMed ID: 7854346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
    Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT
    Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of breast cancer: is there a role for somatostatin and its analogs?
    Boccardo F; Amoroso D
    Chemotherapy; 2001; 47 Suppl 2():62-77. PubMed ID: 11275703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.